Side effects of new Congress may include less advertising.

From The New York Times:

Drug advertising will face hard scrutiny in the new Congress as it considers the renewal of fees that manufacturers pay to speed reviews of new drugs. Read the article (free with registration) here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s